Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PYXS is expected to report earnings to fall 1.91% to -34 cents per share on August 19
Q2'25
Est.
$-0.34
Q1'25
Missed
by $0.02
Q4'24
Missed
by $1.00
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.05
The last earnings report on May 15 showed earnings per share of -34 cents, missing the estimate of -33 cents. With 458.63K shares outstanding, the current market capitalization sits at 76.51M.